Treatment of Hepatitis C Virus Infection with Direct-acting Antiviral Agents Elevates the Serum Small-dense Low-density Lipoprotein Cholesterol Level

OBJECTIVE: The low-density lipoprotein cholesterol (LDL) level is known to increase following the treatment of hepatitis C virus (HCV) infection using direct-acting antiviral agents (DAAs). This study aimed to investigate the changes in the lipid profiles, including small-dense LDL cholesterol (sdLD...

Descripción completa

Detalles Bibliográficos
Autores principales: Hino, Naoyuki, Sasaki, Ryu, Takahashi, Youichi, Koike, Makiko, Fukushima, Masanori, Haraguchi, Masafumi, Honda, Takuya, Miuma, Satoshi, Ozawa, Eisuke, Miyaaki, Hisamitsu, Ichikawa, Tatsuki, Nakao, Kazuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872797/
https://www.ncbi.nlm.nih.gov/pubmed/33456023
http://dx.doi.org/10.2169/internalmedicine.5563-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872797/
https://www.ncbi.nlm.nih.gov/pubmed/33456023
http://dx.doi.org/10.2169/internalmedicine.5563-20

Ejemplares similares